However, there are differences.
Reglan (metoclopramide) and other drugs for gastrointestinal disorders can cause parkinsonism, as can antipsychotics.
Over time, parkinsonism was used to describe symptoms of a range of conditions, including drug-induced parkinsonism.
Illustration by Laura Porter for Verywell Health
Symptoms
Symptoms of pseudoparkinsonism are often very similar to those ofPD symptoms.
It’s important to tell your healthcare provider if you’re experiencing these changes.
Without enough available dopamine, the body is unable to make smooth, purposeful movements.
Diagnosis
There is no specific test to differentiate drug-induced parkinsonism from other types or Parkinsons disease itself.
A healthcare provider will focus on symptoms, your medical history, and results of an initialneurological exam.
Medication use is especially important.
Sometimes drug-induced parkinsonism symptoms continue even after the medication has been discontinued.
Further treatment for drug-induced parkinsonism may include:
Physical therapy and speech therapy may also help.
However, some people may deal with psychiatric symptoms or other problems that arise from changing or discontinuing medication.
Drug-induced parkinsonism can take time to resolve.
Creating a list of priorities for a balanced approach to the day may help as well.
Summary
Pseudoparkinsonism usually refers to drug-induced parkinsonian symptoms, like slow movements or muscle stiffness.
Your healthcare provider can evaluate your symptoms and make an accurate diagnosis.
Treatment typically involves medication changes but also can include physical therapy and other options.
American Association of Psychiatric Pharmacists.Drug-Induced Movement-Disorders.
Stephen C.Causes and Differential Diagnosis of Parkinsons Disease.
American Parkinson Disease Association.What is drug-induced parkinsonism?
2022 Dec 20;18:1129-1142. doi:10.2147/TCRM.S360268
UpToDate.Drug-induced parkinsonism.
Parkinsons Foundation.Coping with a diagnosis.
Shiraiwa N, Tamaoka A, Ohkoshi N.Clinical features of drug-induced Parkinsonism.Neurol Int.
2018 Dec;7(2):233-248. doi:10.1007/s40120-018-0105-0
